ACMG 2019: Welcoming Dr. Robert Steiner to Genetics in Medicine
"I am delighted to be appointed Editor-in-Chief (EIC) of Genetics in Medicine as the journal completes its 20th year.
Genetics in Medicine will have a new emphasis on therapeutics; we are after all Genetics in Medicine. Recent and upcoming advances in therapeutics for genetic conditions are absolutely astounding. My hope is that investigators directing clinical trials in genetic conditions will look to Genetics in Medicine to publish their results. Likewise, researchers who develop novel therapeutic approaches will want to publish early phase trials in the journal. Although we are not a basic science journal, authors should be encouraged to submit ground-breaking basic science or animal model manuscripts with direct links to new therapeutic approaches. Even though there are journals devoted to gene therapy/gene editing, Genetics in Medicine encourages submissions of clinically relevant therapeutic reports utilizing those approaches for rare genetic conditions. Cancer genetics will also be emphasized as an area of interest going forward.
I look forward to hearing your ideas for where you think the journal should go, and for reading your submissions to the journal."
Robert D. Steiner, MD
Editor-in-Chief, Genetics in Medicine
University of Wisconsin School of Medicine and Public Health
